MedPath

Natco Pharma USA LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

FDA:17

Drug Approvals

Diazepam

Approval Date
Apr 24, 2025
FDA

Teriflunomide

Approval Date
Jan 2, 2024
FDA

Armodafinil

Approval Date
Dec 5, 2023
FDA

Risperidone

Approval Date
Nov 15, 2023
FDA

LUBIPROSTONE

Approval Date
Oct 19, 2023
FDA

Ondansetron

Approval Date
Sep 29, 2023
FDA

Gefitinib

Approval Date
Sep 27, 2023
FDA

Alprazolam

Approval Date
Sep 7, 2023
FDA

Megestrol Acetate

Approval Date
Aug 14, 2023
FDA

Diazepam

Approval Date
Aug 5, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.